Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Medical Image Analysis Software Market: Global Forecast to 2031 | AI-Enabled and Cloud-Native Platforms Power 8.1% CAGR Toward USD 6.42 Billion

globenewswire.com
GEHC GE HealthCare is identified as a leading company in the medical image analysis software market, which is experiencing strong growth driven by AI and cloud adoption. The article does not offer specific sentiment for GE HealthCare, but its position in a growing market is a positive indicator. PHI Koninklijke Philips N.V. is named as a leading player in the medical image analysis software market. The market is expected to grow at a CAGR of 8.1%, driven by AI and cloud technologies. The article does not provide specific sentiment for Philips, but its inclusion as a leader in this expanding sector is noteworthy. HOLX Hologic, Inc. is listed among the companies in the medical image analysis software market. The market is expected to grow significantly, driven by AI and cloud technologies. The article does not provide specific sentiment for Hologic, but its presence in this expanding market indicates a neutral position. BRKR Bruker Corporation is listed as a company within the medical image analysis software market. The market is experiencing robust growth driven by AI and cloud technologies. The article does not offer specific sentiment for Bruker, but its inclusion as a participant in this expanding industry indicates a neutral position. MSFT Microsoft Corporation is mentioned as a company involved in the medical image analysis software market, particularly with AI and cloud technologies. The article does not provide specific sentiment for Microsoft, but its involvement in AI and cloud infrastructure, which are key market drivers, suggests a neutral to positive outlook. XRAY Nano-X Imaging Ltd is listed as a company in the medical image analysis software market. The market is expected to grow significantly, driven by AI and cloud adoption. The article does not provide specific sentiment for Nano-X Imaging, but its inclusion as a participant in this expanding sector suggests a neutral outlook.

Medical Image Analysis Software Market: Global Forecast to 2031 | AI-Enabled and Cloud-Native Platforms Power 8.1% CAGR Toward USD 6.42 Billion Dublin, Oct. 21, 2026 (GLOBE NEWSWIRE) -- "Medical Image Analysis Software Market: Global Forecast to 2031" has been added to ResearchAndMarkets.com's offering.

Medical Image Analysis Software Market to Reach USD 6.42 Billion by 2031

The global medical image analysis software market is projected to grow from USD 4.35 billion in 2026 to USD 6.42 billion by 2031, registering a CAGR of 8.1%. Growth is being driven by increasing imaging volumes and the need to reduce radiologist workloads across detection, segmentation, reconstruction, reporting, and clinical decision support workflows.

Hospitals are adopting AI-based medical imaging software to prioritize urgent findings, accelerate interpretation, and manage expanding CT, MRI, ultrasound, mammography, and radiography workloads. Diagnostic imaging centers are investing in cloud-based platforms to improve report turnaround and support remote reading across multiple locations. Academic and research institutions are also increasing their use of AI-enabled imaging software for multi-center clinical studies and disease-specific research involving large, complex datasets.

Additional market momentum is coming from deep learning algorithms, cloud-native platforms, integrated AI-enabled imaging hardware, and enterprise imaging acquisitions. These developments are helping healthcare providers improve diagnostic efficiency, control costs, and streamline clinical workflows.

Deep Learning Led the AI-Enabled Technology Segment in 2025

By AI-enabled technology, the market includes machine learning, deep learning, computer vision, and natural language processing. Deep learning accounted for the largest share in 2025, supported by the growing use of convolutional neural network-based models for detecting fractures, tumors, strokes, and other abnormalities from medical images.

Key applications include automated lesion detection, image segmentation, quantitative measurement, and abnormality classification. Adoption is supported by the ability to train deep learning models using large, multi-institutional datasets and validate solutions for regulatory clearance. Continued investment in advanced algorithms is expected to expand the role of AI across radiology and other imaging-intensive specialties.

Diagnostic Imaging Centers to Record the Fastest End User Growth

The end user market includes hospitals, diagnostic imaging centers, academic and research institutions, and other end users. Diagnostic imaging centers are expected to register the fastest growth during the forecast period due to rising outpatient imaging volumes, demand for shorter reporting times, and increasing reliance on remote and teleradiology reading models.

These centers process high volumes of standardized scans, often with limited on-site radiologist capacity. AI-based triage, detection, and reporting solutions can help improve patient throughput, protect operating margins, and strengthen service delivery. As competition increasingly centers on turnaround time and access, medical image analysis software is becoming a priority investment.

Asia Pacific Expected to Deliver the Highest Regional Growth

Asia Pacific is projected to record the highest growth rate during the forecast period. Expansion is supported by healthcare digitization, growing private hospital networks, broader insurance coverage, and shortages of radiologists relative to imaging demand. India, China, Japan, South Korea, Australia, and the Philippines are key markets as healthcare organizations seek to reduce diagnostic delays and extend specialist imaging services to rural and tier-2/tier-3 areas.

India's Ayushman Bharat Digital Mission had created 799 million digital health IDs and linked 410,000 healthcare facilities as of August 2025. This expanding infrastructure is expected to support long-term demand for connected, cloud-based, AI-enabled medical imaging solutions. The region also benefits from a skilled technical workforce, cost-efficient software development, and a growing base of domestic AI radiology vendors. In 2025, India-based Qure.ai was recognized by Time Magazine as one of the world's most influential AI healthcare companies, with deployments in more than 100 countries and multiple FDA clearances.

Competitive Landscape

Leading medical image analysis software companies include Siemens Healthineers AG, GE HealthCare, Koninklijke Philips N.V., Canon Medical Systems Corporation, FUJIFILM Holdings Corporation, and Aidoc Medical Ltd. The report evaluates established and emerging participants based on company profiles, product portfolios, technology capabilities, partnerships, contracts, product launches, mergers & acquisitions, and market strategies.

Primary research participants were distributed as follows:

Research Scope and Market Opportunities

The report analyzes the market by software type, technology, function, image type, modality, therapeutic area, end user, and region. Covered functions include reconstruction & visualization, detection & localization, segmentation & analysis, registration & comparison, reporting & communication, and clinical decision support. Modalities include X-Ray, CT, MRI, ultrasound, nuclear imaging, mammography, and combined/hybrid systems.

Key growth drivers include radiologist shortages, increasing regulatory clearances for AI-enabled software, integration of AI into imaging hardware, rising chronic disease prevalence, and expanding investment in AI radiology platforms. Opportunities include AI-as-a-service solutions, cloud-native deployment, multimodal AI, foundation models, and expansion across Asia Pacific, Latin America, and Middle East & Africa.

Market constraints include software validation and deployment costs, data privacy requirements, cross-border health data regulations, limited interoperability with legacy PACS/RIS environments, and concerns about algorithm bias and generalizability across diverse patient populations. The report helps market participants assess these factors, evaluate competitive positioning, identify untapped opportunities, and develop informed product, investment, and go-to-market strategies.

Key Attributes:

Key Topics Covered:

1 INTRODUCTION

1.1 STUDY OBJECTIVES

1.2 MARKET DEFINITION

1.3 MARKET SCOPE

1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE

1.3.2 INCLUSIONS AND EXCLUSIONS

1.3.3 YEARS CONSIDERED

1.4 CURRENCY

1.5 STAKEHOLDERS

1.6 SUMMARY OF CHANGES

2 EXECUTIVE SUMMARY

2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS

2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS

2.3 DISRUPTIVE TRENDS SHAPING THE MARKET

2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS

2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

3.1 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET OVERVIEW

3.2 NORTH AMERICA: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE & COUNTRY

3.3 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: GEOGRAPHIC SNAPSHOT

4 MARKET OVERVIEW

4.1 INTRODUCTION

4.2 MARKET DYNAMICS

4.2.1 DRIVERS

4.2.1.1 Rising imaging volumes amid growing radiologist workforce shortages

4.2.1.2 Increasing FDA and regulatory clearances for AI-enabled imaging software

4.2.1.3 Growing demand for early and accurate disease detection

4.2.1.4 Increasing adoption of quantitative and workflow-automation solutions

4.2.2 RESTRAINTS

4.2.2.1 High cost of software validation, integration, and deployment

4.2.2.2 Data privacy and cross-border health data regulations

4.2.3 OPPORTUNITIES

4.2.3.1 Expansion of cloud-native and AI-as-a-service imaging platforms

4.2.3.2 Emerging applications of foundation models and multimodal AI in diagnostic imaging

4.2.3.3 Expansion into new imaging modalities and clinical specialties

4.2.3.4 Integration of image analysis with clinical decision-support and longitudinal care platforms

4.2.4 CHALLENGES

4.2.4.1 Limited interoperability with legacy PACS/RIS and vendor-specific systems

4.2.4.2 Algorithm generalizability and bias across diverse patient populations

4.3 UNMET NEEDS AND WHITE SPACES

4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES

4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

5 INDUSTRY TRENDS

5.1 PORTER'S FIVE FORCES ANALYSIS

5.1.1 BARGAINING POWER OF SUPPLIERS

5.1.2 BARGAINING POWER OF BUYERS

5.1.3 THREAT OF SUBSTITUTES

5.1.4 THREAT OF NEW ENTRANTS

5.1.5 INTENSITY OF COMPETITIVE RIVALRY

5.2 MACROECONOMIC INDICATORS

5.2.1 INTRODUCTION

5.2.2 GDP TRENDS AND FORECAST

5.2.3 TRENDS IN GLOBAL HEALTHCARE INDUSTRY

5.3 VALUE CHAIN ANALYSIS

5.3.1 RESEARCH, IMAGING DATA GENERATION, AND CLINICAL INPUTS

5.3.2 DATA ENGINEERING & AI INFRASTRUCTURE

5.3.3 AI MODEL & PLATFORM DEVELOPMENT

5.3.4 WORKFLOW INTEGRATION & INTEROPERABILITY

5.3.5 SOFTWARE DEPLOYMENT & CLINICAL SERVICES

5.3.6 CLINICAL VALIDATION, MONITORING, AND CONTINUOUS OPTIMIZATION

5.4 ECOSYSTEM ANALYSIS

5.5 PRICING ANALYSIS

5.5.1 MEDICAL IMAGE ANALYSIS SOFTWARE PLATFORMS, BY KEY PLAYERS (2025)

5.5.2 INDICATIVE PRICE FOR MEDICAL IMAGE ANALYSIS SOFTWARE, BY REGION (2025)

5.6 KEY CONFERENCES AND EVENTS, 2026-2027

5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS

5.8 INVESTMENT AND FUNDING SCENARIO

5.9 CASE STUDY ANALYSIS

5.10 IMPACT OF 2025 US TARIFF - MEDICAL IMAGE ANALYSIS SOFTWARE MARKET

5.10.1 INTRODUCTION

5.10.2 KEY TARIFF RATES

5.10.3 PRICE IMPACT ANALYSIS

5.10.4 IMPACT ON COUNTRY/REGION

5.10.4.1 US

5.10.4.2 Europe

5.10.4.3 Asia Pacific

5.10.5 IMPACT ON END USERS

5.10.5.1 Hospitals and health systems

5.10.5.2 Diagnostic imaging centers

5.10.5.3 Specialty clinics and ambulatory care providers

5.10.5.4 Pharmaceutical and biotechnology companies

5.10.5.5 Academic and research institutions

6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

6.1 KEY EMERGING TECHNOLOGIES

6.1.1 AI-POWERED DEEP LEARNING AND FOUNDATION MODELS

6.1.2 CLOUD-NATIVE MEDICAL IMAGING AND AI-AS-A-SERVICE

6.1.3 ADVANCED 3D VISUALIZATION, SEGMENTATION, AND QUANTITATIVE IMAGING

6.2 COMPLEMENTARY TECHNOLOGIES

6.2.1 CLOUD COMPUTING AND EDGE COMPUTING

6.2.2 INTEROPERABILITY, PACS/VNA, AND CLINICAL DATA INTEGRATION

6.3 TECHNOLOGY/PRODUCT ROADMAP

6.4 PATENT ANALYSIS

6.4.1 PATENT PUBLICATION TRENDS FOR MEDICAL IMAGE ANALYSIS SOFTWARE MARKET

6.4.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS

6.5 FUTURE APPLICATIONS

6.5.1 EARLY DISEASE DETECTION AND SCREENING

6.5.2 PERSONALIZED TREATMENT PLANNING AND THERAPY GUIDANCE

6.5.3 LONGITUDINAL DISEASE MONITORING AND TREATMENT RESPONSE

6.6 IMPACT OF AI/GEN AI ON MEDICAL IMAGE ANALYSIS SOFTWARE SOLUTIONS

6.6.1 INTRODUCTION

6.6.2 CASE STUDIES RELATED TO AI/GEN AI IMPLEMENTATION

6.6.2.1 AI-powered chest X-ray analysis for tuberculosis screening

6.6.3 IMPACT OF AI/GEN AI ON INTERCONNECTED & ADJACENT ECOSYSTEMS

6.6.3.1 PACS/VNA & enterprise imaging market

6.6.3.2 AI in medical imaging market

6.6.3.3 EHR/Clinical decision support market

6.6.4 USER READINESS & IMPACT ASSESSMENT

6.6.4.1 User readiness

6.6.4.1.1 User A: Healthcare providers

6.6.4.1.2 User B: Diagnostic imaging centers

6.6.4.2 Impact assessment

6.6.4.2.1 User A: Healthcare providers

6.6.4.2.2 User B: Diagnostic imaging centers

7 REGULATORY LANDSCAPE

7.1 REGIONAL REGULATIONS AND COMPLIANCE

7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

7.1.2 REGULATORY FRAMEWORK

7.1.2.1 North America

7.1.2.2 Europe

7.1.2.3 ASIA PACIFIC

7.1.2.4 LATIN AMERICA

7.1.2.5 MIDDLE EAST & AFRICA

7.1.3 INDUSTRY STANDARDS

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

8.1 INTRODUCTION

8.2 DECISION-MAKING PROCESS

8.3 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA

8.3.1 KEY STAKEHOLDERS IN BUYING PROCESS

8.3.2 BUYING CRITERIA

8.4 ADOPTION BARRIERS & INTERNAL CHALLENGES

8.5 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES

8.5.1 UNMET NEEDS

8.5.2 END USER EXPECTATIONS

8.6 MARKET PROFITABILITY

9 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER

9.1 INTRODUCTION

9.2 HOSPITALS

9.2.1 INCREASING ADOPTION OF ADVANCED MEDICAL IMAGING AND AI IN HOSPITALS

9.3 DIAGNOSTIC IMAGING CENTERS

9.3.1 RISING DEMAND FOR EFFICIENT AND HIGH-VOLUME DIAGNOSTIC IMAGING TO BOOST MARKET

9.4 ACADEMIC & RESEARCH INSTITUTIONS

9.4.1 INCREASING USE OF MEDICAL IMAGE ANALYSIS SOFTWARE IN RESEARCH TO BOOST SEGMENT

9.5 OTHER END USERS

9.5.1 EXPANDING USE OF MEDICAL IMAGE ANALYSIS BEYOND CONVENTIONAL HEALTHCARE SETTING TO BOOST SEGMENT

10 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY FUNCTION

10.1 INTRODUCTION

10.2 RECONSTRUCTION & VISUALIZATION

10.2.1 INCREASING DEMAND FOR HIGH-QUALITY IMAGE RECONSTRUCTION AND 3D VISUALIZATION TO BOOST SEGMENT

10.3 DETECTION & LOCALIZATION

10.3.1 RISING DEMAND FOR AUTOMATED DETECTION AND LOCALIZATION OF ABNORMALITIES

10.4 SEGMENTATION & ANALYSIS

10.4.1 INCREASING ADOPTION OF AUTOMATED SEGMENTATION AND QUANTITATIVE IMAGE ANALYSIS

10.5 REGISTRATION & COMPARISON

10.5.1 GROWING NEED FOR ACCURATE ALIGNMENT AND COMPARISON OF MULTIMODAL MEDICAL IMAGES TO BOOST GROWTH

10.6 REPORTING & COMMUNICATION

10.6.1 GROWING ADOPTION OF AI-POWERED RADIOLOGY REPORTING AND WORKFLOW AUTOMATION TO DRIVE SEGMENT

10.7 CLINICAL DECISION SUPPORT

10.7.1 INCREASING ADOPTION OF AI-ASSISTED CLINICAL DECISION SUPPORT

11 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY IMAGE TYPE

11.1 INTRODUCTION

11.2 3D IMAGING

11.2.1 GROWING ADOPTION OF 3D IMAGING FOR DETAILED ANATOMICAL VISUALIZATION TO BOOST SEGMENT

11.3 4D IMAGING

11.3.1 GROWING DEMAND FOR DYNAMIC AND FUNCTIONAL MEDICAL IMAGING TO DRIVE SEGMENT

11.4 2D IMAGING

11.4.1 CONTINUED DEMAND FOR 2D IMAGING IN ROUTINE DIAGNOSTIC APPLICATIONS - KEY DRIVER

12 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY

12.1 INTRODUCTION

12.2 RADIOGRAPHY (X-RAY)

12.2.1 INCREASING ADOPTION OF AI-ENABLED X-RAY ANALYSIS AND WORKFLOW AUTOMATION TO DRIVE SEGMENT

12.3 COMPUTED TOMOGRAPHY (CT)

12.3.1 SEGMENT DRIVEN BY AI-ENABLED CT IMAGE ANALYSIS FOR RECONSTRUCTION AND DETECTION

12.3.2 HIGH-END SLICE CT

12.3.2.1 Growing demand for high-resolution and advanced CT imaging - key driver

12.3.3 MID-END SLICE CT

12.3.3.1 Demand for versatile CT systems with automated analysis to boost growth

12.3.4 LOW-END SLICE CT

12.3.4.1 Expanding access to cost-efficient CT imaging to propel growth

12.4 MAGNETIC RESONANCE IMAGING (MRI)

12.4.1 INCREASING ADOPTION OF AI-POWERED MRI RECONSTRUCTION AND WORKFLOW AUTOMATION TO DRIVE MARKET

12.4.2 CLOSED MRI SYSTEMS

12.4.2.1 Increasing demand for high-resolution and AI-optimized MRI to drive segment

12.4.3 OPEN MRI SYSTEMS

12.4.3.1 Expanding access to patient-friendly and specialized MRI to drive segment

12.5 ULTRASOUND IMAGING

12.5.1 INCREASING ADOPTION OF AI-POWERED ULTRASOUND IMAGING AND WORKFLOW AUTOMATION TO DRIVE MARKET

12.5.2 2D ULTRASOUND SYSTEMS

12.5.2.1 Expanding use of AI-assisted analysis in routine 2D ultrasound to drive segment

12.5.3 3D & 4D ULTRASOUND SYSTEMS

12.5.3.1 Increasing demand for volumetric and dynamic ultrasound analysis to boost segment

12.5.4 DOPPLER IMAGING

12.5.4.1 Growing demand for automated blood-flow assessment

12.6 NUCLEAR IMAGING

12.6.1 GROWING ADOPTION OF QUANTITATIVE ANALYSIS IN NUCLEAR IMAGING TO BOOST SEGMENT

12.6.2 POSITRON EMISSION TOMOGRAPHY (PET)

12.6.2.1 Increasing use of quantitative PET for molecular and functional imaging to drive segment

12.6.3 SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT)

12.6.3.1 Growing demand for quantitative SPECT in theranostics and cardiovascular imaging

12.7 MAMMOGRAPHY

12.7.1 INCREASING ADOPTION OF AI-POWERED MAMMOGRAPHY FOR BREAST CANCER DETECTION TO BOOST SEGMENT

12.8 COMBINED/HYBRID MODALITIES

12.8.1 GROWING ADOPTION OF HYBRID IMAGING FOR INTEGRATED ANATOMICAL AND FUNCTIONAL ANALYSIS TO BOOST SEGMENT

12.8.2 PET/CT

12.8.2.1 Increasing demand for quantitative PET/CT in oncology

12.8.3 SPECT/CT

12.8.3.1 Increasing use of SPECT/CT for quantitative assessment and dosimetry

12.8.4 PET/MR

12.8.4.1 Growing demand for high-resolution multimodal brain and oncology imaging to propel demand

12.9 OTHERS

13 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TECHNOLOGY

13.1 INTRODUCTION

13.2 AI-ENABLED TECHNOLOGY

13.2.1 INCREASING ADOPTION OF AI FOR AUTOMATED AND QUANTITATIVE IMAGE ANALYSIS

13.2.2 MACHINE LEARNING

13.2.2.1 Increasing use of machine learning for automated medical image analysis to drive segment

13.2.3 DEEP LEARNING

13.2.3.1 Growing use of deep learning for high-precision medical image reconstruction and analysis to boost segment

13.2.4 COMPUTER VISION

13.2.4.1 Increasing adoption of computer vision for automated detection and interpretation of medical images to boost segment

13.2.5 NATURAL LANGUAGE PROCESSING (NLP)

13.2.5.1 Increasing use of NLP for automated radiology reporting and clinical information extraction

13.3 CONVENTIONAL TECHNOLOGY

13.3.1 CONTINUED DEMAND FOR RELIABLE AND ESTABLISHED IMAGE PROCESSING

14 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY THERAPEUTIC AREA

14.1 INTRODUCTION

14.2 CARDIOLOGY

14.2.1 INCREASING ADOPTION OF AI-POWERED CARDIOVASCULAR IMAGE ANALYSIS TO DRIVE MARKET

14.3 ONCOLOGY

14.3.1 INCREASING USE OF MEDICAL IMAGING AND AI FOR CANCER DETECTION AND TREATMENT MONITORING TO BOOST SEGMENT

14.4 NEUROLOGY

14.4.1 RISING DEMAND FOR AI-ASSISTED NEUROLOGICAL IMAGING AND EARLY DISEASE DETECTION

14.5 ORTHOPEDICS

14.5.1 GROWING ADOPTION OF AI-ENABLED IMAGING FOR ORTHOPEDIC DIAGNOSIS AND SURGICAL PLANNING

14.6 DENTAL

14.6.1 INCREASING ADOPTION OF AI-ENABLED DENTAL IMAGING AND DIAGNOSTIC ANALYSIS TO BOOST SEGMENT

14.7 OBSTETRICS & GYNECOLOGY

14.7.1 INCREASING ADOPTION OF AI-ENABLED OBSTETRIC AND GYNECOLOGICAL IMAGING

14.8 MAMMOGRAPHY/BREAST IMAGING

14.8.1 GROWING ADOPTION OF AI FOR BREAST CANCER DETECTION AND MAMMOGRAPHY WORKFLOW OPTIMIZATION

14.9 OTHER THERAPEUTIC AREAS

14.9.1 EXPANDING APPLICATIONS OF MEDICAL IMAGE ANALYSIS ACROSS EMERGING THERAPEUTIC AREAS

15 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE

15.1 INTRODUCTION

15.2 INTEGRATED SOFTWARE

15.2.1 GROWING INTEGRATION OF AI-POWERED IMAGE ANALYSIS INTO CLINICAL WORKFLOWS TO BOOST SEGMENT

15.3 STANDALONE SOFTWARE

15.3.1 INCREASING ADOPTION OF AI-ENABLED STANDALONE IMAGE ANALYSIS SOLUTIONS TO DRIVE SEGMENT

16 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY REGION

16.1 INTRODUCTION

16.2 NORTH AMERICA

16.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA

16.2.2 US

16.2.2.1 Growing demand for faster diagnostics to boost demand

16.2.3 CANADA

16.2.3.1 Increasing investments in healthcare data infrastructure and medical imaging AI to drive market

16.3 EUROPE

16.3.1 MACROECONOMIC OUTLOOK FOR EUROPE

16.3.2 GERMANY

16.3.2.1 Growing adoption of AI-powered medical imaging and radiology solutions to drive market

16.3.3 FRANCE

16.3.3.1 Increasing adoption of AI-based medical imaging solutions to drive market

16.3.4 UK

16.3.4.1 Increasing government support for AI-enabled medical imaging to boost market

16.3.5 ITALY

16.3.5.1 Growing adoption of AI in medical imaging and diagnostic workflows to boost market

16.3.6 SPAIN

16.3.6.1 Expanding adoption of AI-powered medical imaging solutions to boost market

16.3.7 REST OF EUROPE

16.4 ASIA PACIFIC

16.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC

16.4.2 CHINA

16.4.2.1 Expanding deployment of AI-powered medical imaging solutions to boost market

16.4.3 JAPAN

16.4.3.1 Growing adoption of AI in medical imaging and radiology to boost market

16.4.4 INDIA

16.4.4.1 Increasing investment in AI-powered medical imaging and diagnostic infrastructure to drive market

16.4.5 AUSTRALIA

16.4.5.1 Increasing investment in AI-enabled medical imaging and diagnostic infrastructure

16.4.6 SOUTH KOREA

16.4.6.1 Strong government and industry investment in AI-enabled medical imaging

16.4.7 REST OF ASIA PACIFIC

16.5 LATIN AMERICA

16.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA

16.5.2 BRAZIL

16.5.2.1 Increasing investment in AI infrastructure and medical imaging to drive market

16.5.3 MEXICO

16.5.3.1 Increasing deployment of AI-enabled medical imaging infrastructure

16.5.4 REST OF LATIN AMERICA

16.5.4.1 Growing adoption of AI in medical imaging to boost market

16.6 MIDDLE EAST & AFRICA

16.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA

16.6.2 GCC

16.6.2.1 Expanding healthcare digitalization and AI adoption to drive market

16.6.2.2 Saudi Arabia

16.6.2.2.1 Accelerating adoption of AI in medical imaging - key driver

16.6.2.3 UAE

16.6.2.3.1 Government-led AI initiatives for smart healthcare to boost market

16.6.2.4 Rest of GCC

16.6.2.4.1 Increasing healthcare digitization to drive market

16.6.3 SOUTH AFRICA

16.6.3.1 Growing adoption and readiness for AI-enabled medical imaging to boost market

16.6.4 REST OF MIDDLE EAST & AFRICA

17 COMPETITIVE LANDSCAPE

17.1 INTRODUCTION

17.2 KEY PLAYER STRATEGIES/RIGHT TO WIN

17.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET

17.3 REVENUE ANALYSIS, 2021-2025

17.4 MARKET SHARE ANALYSIS, 2025

17.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025

17.5.1 STARS

17.5.2 EMERGING LEADERS

17.5.3 PERVASIVE PLAYERS

17.5.4 PARTICIPANTS

17.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025

17.5.5.1 Company footprint

17.5.5.2 Region footprint

17.5.5.3 Type footprint

17.5.5.4 Technology footprint

17.5.5.5 Image Type footprint

17.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025

17.6.1 PROGRESSIVE COMPANIES

17.6.2 RESPONSIVE COMPANIES

17.6.3 DYNAMIC COMPANIES

17.6.4 STARTING BLOCKS

17.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025

17.6.5.1 Detailed list of key startups/SMEs

17.6.5.2 Competitive benchmarking of key startups/SMEs

17.7 COMPANY VALUATION AND FINANCIAL METRICS

17.8 BRAND/SOFTWARE COMPARISON

17.9 COMPETITIVE SCENARIO

17.9.1 PRODUCT/SERVICE LAUNCHES & UPGRADES

17.9.2 DEALS

17.9.3 EXPANSIONS

18 COMPANY PROFILES

18.1 KEY PLAYERS

18.1.1 SIEMENS HEALTHINEERS AG

18.1.1.1 Products/solutions/services offered

18.1.1.2 Recent developments

18.1.1.2.1 Product launches & upgrades

18.1.1.2.2 Deals

18.1.1.2.3 Expansions

18.1.1.3 Analyst's view

18.1.1.3.1 Key strengths

18.1.1.3.2 Strategic choices

18.1.1.3.3 Weaknesses and competitive threats

18.1.2 GE HEALTHCARE

18.1.2.1 Business overview

18.1.2.2 Products/solutions/services offered

18.1.2.3 Recent developments

18.1.2.3.1 Product launches & upgrades

18.1.2.3.2 Deals

18.1.2.4 Analyst's view

18.1.2.4.1 Key strengths

18.1.2.4.2 Strategic choices

18.1.2.4.3 Weaknesses and competitive threats

18.1.3 KONINKLIJKE PHILIPS N.V.

18.1.3.1 Business overview

18.1.3.2 Products/solutions/services offered

18.1.3.3 Recent developments

18.1.3.3.1 Product launches & upgrades

18.1.3.3.2 Deals

18.1.3.3.3 Expansions

18.1.3.4 Analyst's view

18.1.3.4.1 Key strengths

18.1.3.4.2 Strategic choices

18.1.3.4.3 Weaknesses and competitive threats

18.1.4 CANON MEDICAL SYSTEMS CORPORATION

18.1.4.1 Business overview

18.1.4.2 Products/solutions/services offered

18.1.4.3 Recent developments

18.1.4.3.1 Product launches & upgrades

18.1.4.3.2 Deals

18.1.5 FUJIFILM HOLDINGS CORPORATION

18.1.5.1 Business overview

18.1.5.2 Products/solutions/services offered

18.1.5.3 Recent developments

18.1.5.3.1 Product launches & upgrades

18.1.5.3.2 Deals

18.1.6 AGFA-GEVAERT N.V.

18.1.6.1 Business overview

18.1.6.2 Products/solutions/services offered

18.1.6.3 Recent developments

18.1.6.3.1 Product launches & upgrades

18.1.6.3.2 Deals

18.1.7 CARESTREAM HEALTH

18.1.7.1 Business overview

18.1.7.2 Products/solutions/services offered

18.1.7.3 Recent developments

18.1.7.3.1 Product launches & upgrades

18.1.7.3.2 Deals

18.1.8 HOLOGIC, INC.

18.1.8.1 Business overview

18.1.8.2 Products/solutions/services offered

18.1.8.3 Recent developments

18.1.8.3.1 Product launches & upgrades

18.1.8.3.2 Deals

18.1.9 MERATIVE

18.1.9.1 Business overview

18.1.9.2 Products/solutions/services offered

18.1.9.3 Recent developments

18.1.9.3.1 Product launches & upgrades

18.1.9.3.2 Deals

18.1.9.3.3 Expansions

18.1.10 SECTRA AB

18.1.10.1 Business overview

18.1.10.2 Products/solutions/services offered

18.1.10.3 Recent developments

18.1.10.3.1 Product launches & upgrades

18.1.10.3.2 Deals

18.1.11 BRUKER CORPORATION

18.1.11.1 Business overview

18.1.11.2 Products/solutions/services offered

18.1.12 QUIBIM

18.1.12.1 Business overview

18.1.12.2 Products/solutions/services offered

18.1.12.3 Recent developments

18.1.12.3.1 Deals

18.1.13 MIRADA MEDICAL LTD.

18.1.13.1 Business overview

18.1.13.2 Products/solutions/services offered

18.1.13.3 Recent developments

18.1.13.3.1 Product launches & upgrades

18.1.13.3.2 Deals

18.1.13.4 Other developments

18.1.14 MEDIAN TECHNOLOGIES

18.1.14.1 Business overview

18.1.14.2 Products/solutions/services offered

18.1.14.3 Recent developments

18.1.14.3.1 Product launches & upgrades

18.1.14.3.2 Deals

18.1.15 ELUCID

18.1.15.1 Business overview

18.1.15.2 Products/solutions/services offered

18.1.15.3 Recent developments

18.1.15.3.1 Product launches & upgrades

18.1.15.3.2 Other developments

18.1.16 RAPIDAI, INC.

18.1.16.1 Business overview

18.1.16.2 Products/solutions/services offered

18.1.16.3 Recent developments

18.1.16.3.1 Product launches & upgrades

18.1.16.3.2 Deals

18.1.17 MICROSOFT CORPORATION

18.1.17.1 Business overview

18.1.17.2 Products/solutions/services offered

18.1.17.3 Recent developments

18.1.17.3.1 Product launches & upgrades

18.1.17.3.2 Deals

18.1.18 TEMPUS AI, INC.

18.1.18.1 Business overview

18.1.18.2 Products/solutions/services offered

18.1.18.3 Recent developments

18.1.18.3.1 Product launches & upgrades

18.1.18.3.2 Deals

18.1.19 NANO-X IMAGING LTD

18.1.19.1 Business overview

18.1.19.2 Products/solutions/services offered

18.1.19.3 Recent developments

18.1.19.3.1 Product launches & upgrades

18.1.19.3.2 Deals

18.1.20 CONTEXTVISION AB

18.1.20.1 Business overview

18.1.20.2 Products/solutions/services offered

18.1.20.3 Recent developments

18.1.20.3.1 Product launches & upgrades

18.1.20.3.2 Deals

18.2 OTHER PLAYERS

18.2.1 VIZ.AI, INC.

18.2.2 AIDOC MEDICAL LTD.

18.2.3 AVICENNA.AI

18.2.4 CLEERLY, INC.

18.2.5 OVERJET, INC.

19 RESEARCH METHODOLOGY

19.1 RESEARCH APPROACH

19.1.1 SECONDARY RESEARCH

19.1.1.1 Key data from secondary sources

19.1.2 PRIMARY RESEARCH

19.1.2.1 Key data from primary sources

19.1.2.2 Insights from primary experts

19.2 RESEARCH METHODOLOGY DESIGN

19.3 MARKET SIZE ESTIMATION

19.4 MARKET BREAKDOWN DATA TRIANGULATION

19.5 MARKET SHARE ESTIMATION

19.6 STUDY ASSUMPTIONS

19.7 LIMITATIONS

19.7.1 SCOPE-RELATED LIMITATIONS

19.7.2 METHODOLOGY-RELATED LIMITATIONS

19.8 RISK ASSESSMENT

20 APPENDIX

20.1 DISCUSSION GUIDE

20.2 KNOWLEDGESTORE: THE SUBSCRIPTION PORTAL

20.3 CUSTOMIZATION OPTIONS

20.4 RELATED REPORTS

20.5 AUTHOR DETAILS

LIST OF TABLES [552]

LIST OF FIGURES [52]

For more information about this report visit https://www.researchandmarkets.com/r/gv1e1u

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.